快要 飞的 《药股》 讨论区

m.i.k.e

原帖由 jochen 于 8-10-2009 04:26 PM 发表

讓我誠懇的問你。。。
你有 和銀行 借錢嗎？？

yong 你買了（buy）嗎？
我的mac 沒簡體。。。我分不清
買和賣。。。。。

讓我誠懇的問你。。。......(哟....怎么这样客气? )
你有 和銀行 借錢嗎？？.......(房贷就有..... )

yong 你買了（buy）嗎？..........(还没有.)
我的mac 沒簡體。。。我分不清......(好有水,用 MAC. )
買和賣。。。。。

m.i.k.e

原帖由 葉芬 于 8-10-2009 04:22 PM 发表




雖然我的WL是長些，不過里邊有好多珍珠。
RPRX 就是其中一只，可惜有看沒買。

干嘛笑到这么狰狞?

有赚到的才是珍珠,没赚到的都是玻璃.........

葉芬

原帖由 m.i.k.e 于 8-10-2009 04:36 PM 发表


干嘛笑到这么狰狞?

有赚到的才是珍珠,没赚到的都是玻璃.........

你一天不“制”我都不行。。



P/s:看來我要考慮把房子 再融資。。要把我的玻璃變珍珠！

[ 本帖最后由 葉芬 于 8-10-2009 04:40 PM 编辑 ]

jochen

原帖由 葉芬 于 8-10-2009 04:38 PM 发表



你一天不“制”我都不行。。



P/s:看來我要考慮把房子 再融資。。要把我的玻璃變珍珠！

我原本也想 建议 麦麦 这样做。。。

你们玩 的 好大。。。。
我是只   老鼠。。。。玩小小而已。。。

葉芬

原帖由 jochen 于 8-10-2009 04:44 PM 发表

我原本也想 建议 麦麦 这样做。。。

你们玩 的 好大。。。。
我是只   老鼠。。。。玩小小而已。。。

這不叫玩，這叫投資！

YMZ09.CBT

Mini Dow Jones Indus.-$5 Dec 09

9,760.00  4:38am ET

87.00 (0.90%)

[ 本帖最后由 葉芬 于 8-10-2009 04:50 PM 编辑 ]

雨若情

这里讲投资会被高级生物批评哦。

小心小心

[ 本帖最后由 雨若情 于 8-10-2009 05:40 PM 编辑 ]

雨若情

1股usd158.84
我眼睛有没有花？

m.i.k.e

原帖由 终景 于 8-10-2009 10:15 AM 发表
我也是個新人﹐今年四月才開始投資/投機美股。要多謝napster給我的啟發。還有﹐芬姐﹐ 你人蛮好的。。。

叶芬的人好是众所皆知的.只可惜他没有养成借钱给朋友的习惯.....

葉芬

原帖由 m.i.k.e 于 8-10-2009 06:48 PM 发表


叶芬的人好是众所皆知的.只可惜他没有养成借钱给朋友的习惯.....

呵呵 講$$$傷感情leh...

miku

cvm又跌了。。几时有好消息？

葉芬

原帖由 miku 于 8-10-2009 11:23 PM 发表
cvm又跌了。。几时有好消息？

自己看做辦吧。。。
今天的1.42- 1.45 還是算便宜。星期2投機的放了。。
然後再買進..新的Contract T+5 至下星期4。
拿票的早已拿票，投機的票只要確定會到18號就行。

http://acr.confex.com/acr/2009/webprogram/Paper10996.html



另一信息。。。

  Cel Sci: Job Listings Are a Good Sign
      
                  by: VFC's Stock House              October 08, 2009



http://seekingalpha.com/article/165524-cel-sci-job-listings-are-a-good-sign?source=yahoo

What's left to say about Cel Sci Corp. (CVM)?That company and its stock have received a heck of a lot of press overthe past couple of weeks and I maintain my opinion that - in my opinion- the stock will pay off based on the potential of Multikine; and asI've said before, the LEAPS swine flu potential is icing on the cake.
Additionally,the company is very likely to pull in some fairly significant revenuefrom rentees who are expected to rent space in the new facility. Itcould be assumed that any money raised from the rent will help fund theMultikine Phase III trial, which I expect will get underway in thenot-so-distant future.
I'm basing that opinion on previous released information and the fact that the Cel Sci website has recently added a number of job listings- all having to do with vaccine manufacturing.
Inmy opinion, the job listings are a good indicator that Cel Sci is infact preparing for the Multikine Phase III trial - contrary to what thenaysayers have been saying over the past couple of weeks.
As always, CVM is a stock to watch and buy the dips if you're still accumulating.
Disclosure: VFC is long CVM.

[ 本帖最后由 葉芬 于 8-10-2009 11:44 PM 编辑 ]

miku

我是投机的，1.47是很好的价位，等几天起一点就会卖了

jochen

原帖由 miku 于 8-10-2009 11:55 PM 发表
我是投机的，1.47是很好的价位，等几天起一点就会卖了

我想明天 才来买。。。
通常 拜5。。。人人都会抛。。。。


希望 明天可以捡到便宜。。。。

miku

cvm我看到太多ctic的影子了。。还是跌=买，有赚一点=卖。

m.i.k.e

Cardium Therapeutics Inc.

PRICES

Date Open High Low Close Volume Adj Close* 8-Oct-09 1.51 1.71 1.50 1.53 1,027,000 1.53 7-Oct-09 1.47 1.54 1.45 1.50 149,000 1.50 6-Oct-09 1.56 1.59 1.45 1.47 220,200 1.47 5-Oct-09 1.31 1.62 1.30 1.59 547,500 1.59 2-Oct-09 1.41 1.45 1.29 1.30 372,400 1.30 1-Oct-09 1.79 1.79 1.23 1.40 781,100 1.40 30-Sep-09 1.77 1.84 1.62 1.62 498,100 1.62 29-Sep-09 1.80 1.80 1.73 1.77 256,100 1.77 28-Sep-09 1.71 1.78 1.71 1.76 347,500 1.76 25-Sep-09 1.66 1.74 1.66 1.69 162,700 1.69 24-Sep-09 1.71 1.75 1.65 1.65 238,400 1.65 23-Sep-09 1.71 1.77 1.70 1.70 67,300 1.70 22-Sep-09 1.75 1.78 1.70 1.70 180,100 1.70 21-Sep-09 1.66 1.74 1.65 1.73 85,900 1.73 18-Sep-09 1.62 1.73 1.62 1.66 357,500 1.66 17-Sep-09 1.84 1.84 1.66 1.73 135,000 1.73 16-Sep-09 1.76 1.83 1.76 1.80 105,200 1.80 15-Sep-09 1.78 1.80 1.64 1.76 287,900 1.76 14-Sep-09 1.75 2.25 1.75 1.78 733,400 1.78 11-Sep-09 1.78 1.85 1.72 1.76 63,600 1.76 10-Sep-09 1.85 2.02 1.72 1.77 294,300 1.77 9-Sep-09 1.86 1.90 1.81 1.84 74,200 1.84 8-Sep-09 1.85 1.95 1.82 1.87 71,700 1.87 4-Sep-09 1.82 2.03 1.70 1.89 135,400 1.89 3-Sep-09 1.91 1.91 1.72 1.75 93,600 1.75 2-Sep-09 1.80 1.90 1.75 1.85 143,000 1.85 1-Sep-09 1.88 1.98 1.80 1.80 94,500 1.80

昨晚的成交量超大......研究报告就要公布了. 是吉?是凶?

http://www.tradingmarkets.com/.site/news/TOP%20STORY/2567640/

葉芬

CVM - 1.4多的價錢還是OK的。。。

葉芬

今天股市沒有什么新聞。
美股Future 跌了些些。。

YMZ09.CBT        Mini Dow Jones Indus.-$5 Dec 09        9,734.00  5:35am ET        Down 13.00 (0.13%)       





再來個題外話：

近排國際區熱鬧的很。。
來參觀的人數節節上升。
呵呵 現在再加多個編輯作者，遲些更不得了

wobushi

大家有点paiseh拉，不敢来废一废

m.i.k.e

SPPI
6.21
-0.21 (-3.27%)
Pre-market: 5.13 -1.08 (-17.39%) <<<<< 没有良心的 FDA, 害我亏钱.

http://www.reuters.com/article/h ... USTRE5982C420091009

Fusilev 会不会像 Zevalin 那样延后一两个月后又被FDA 通过?
我看还是收起来等年尾的 EOquin.

http://www.easybourse.com/bourse ... fusilev-drug-742973

[ 本帖最后由 m.i.k.e 于 9-10-2009 08:14 PM 编辑 ]

葉芬

原帖由 m.i.k.e 于 9-10-2009 08:05 PM 发表
SPPI
6.21
-0.21 (-3.27%)
Pre-market: 5.13 -1.08 (-17.39%)  

快... 加碼CVM！ 年尾過個大肥年！


                                                                Great blog article                       
                                                                                                                                                        Why invest in CEL-SCI Corp (CVM)


With the amount of hype and madness this company has been gettingrecently it’s becoming increasing more difficult to sort thru theenormous amount of BS that is out there. Majority of the madness iscoming from either not understanding what the company and its productsare about or having ulterior motives for putting out information thatis either biased or flat out wrong. The fact is that majority of whatyou will read as of recent is simply some guys opinion and nothingmore. It’s been said over and over again that each investor should dohis/her own research and due diligence when researching a stock and notrely on opinions. However when money is on the table and information isscarce—many will fall prey to the predators that lurk in the blue wideyonder that is the internet. I spend a considerable amount of timeresearching this company and I will post that research for everybody tomake their own decisions. I am not a journalist or a blogger so don’texpect some grand insight or witty article. All I have is links toverifiable sources such as government websites and other confirmablesources not some website a 16 year old put up overnight.

First some basic information about the company:


CEL-SCI Corporation is developing new immune system based treatmentsfor cancer and infectious diseases. The Company's most advancedproduct, Multikine, manufactured using the company's proprietary cellculture technologies, is being developed for the treatment of cancer.Multikine is designed to target the tumor micro-metastises that aremostly responsible for treatment failure. The basic idea of Multikineis to make current cancer treatments more successful. The leadindication is advanced primary head & neck cancer. Since Multikineis not tumor specific, it may also be applicable in many other solidtumors. The Company also owns a pre-clinical technology calledL.E.A.P.S., Ligand Epitope Antigen Presentation System. The leadproduct derived from this technology is the CEL-1000 peptide which hasshown protection in animals against herpes, malaria and cancer. Withthe help of government grants and US Army and US Navy collaborations,CEL-1000 is now being tested against viral encephalitis, West NileVirus, SARS, Vaccinia, Smallpox, herpes, malaria and other agents. Ifthe bio-terrorism tests are successful, CEL-SCI is likely to pushCEL-1000 for potential bio-terrorism disease indications to gainaccelerated approval.

Go to Marketwatch for more basic information…


The company holds several patents in the field and has several in pre-grant status. See the links below from United States Patent and Trademark Office.

Patents currently held…

Patents in pre-grant status…




The company has two products.
Cancer – Multikine&#174;

Multikine&#174;, CEL-SCI's flagship cancer product, is the firstimmunotherapeutic agent being developed as a first-line standard ofcare cancer treatment. Multikine&#174; is a different kind of weapon in thefight against cancer; one that harnesses our body's natural ability tofight tumors.
Multikine&#174; is also the first of a new class of cancer immunotherapydrugs. It is the first comprehensive immunotherapy and the first ImmuneSIMULATOR.

Infectious Diseases - L.E.A.P.S.&#8482;

L.E.A.P.S.&#8482; is a patented, T-cell modulation, peptide epitope deliverytechnology that enables CEL-SCI to design and synthesize proprietarypeptide immunogens. L.E.A.P.S.&#8482; compounds consist of a small T-cellbinding peptide ligand linked with a disease-associated peptide antigen.

This new technology has been shown in several animal models topreferentially direct immune response to a cellular (e.g. T-cell),humoral (antibody) or mixed pathway. Any disease for which antigenicepitope sequences have been identified, such as: infectious diseases,cancer, autoimmune diseases, allergic asthma and allergy, and selectCNS diseases (e.g., Alzheimer’s) are potential candidates for thistechnology platform.


See the company’s product page for more information.


Since I have a very basic understanding of biochemistry and by no meansam I an expert, I’ll attempt to explain what they are currently usedfor. Both of the drugs are immunotherapy drugs—their role is to helpthe immune system during treatment not flat out cure the disease. Therehas been a number of posts and blogs about supposed statements thatcompany has made regarding what these drugs do.

For example many have the wrong impression that LEAPS-H1N1 treatmentis a vaccine for the swine flu and have created their arguments aroundthis point; when the facts are that the drug is not a vaccine ratherits role is to help the patients who already have the H1N1 to recover.Personally I think this is the right approach since the virus has shownsigns of mutation and resistance to certain conventional treatments andthe market is already swamped with many other companies developingvaccines. Read more about the LEAPS treatment.

Multikine has essentially the same role expect in cancer cells.Recently talked about use is in reducing the size of the tumor in headand neck cancer patients so that the doctors can performs surgerieseasier and with the least amount of cosmetic damage. It has also usesin treating cervical cancer.

See information from Pharmaceutical Research and Manufacturers of America (PhRMA) …

In addition Multikine has been approved by the FDA for phase III trials. Multikine has also been granded the Orphan Status by the FDA.

See information from FDA website (Excel Spreadsheet)
What is Orphan Status (FDA website)

Search the FDA orphan status database (FDA website)


In addition CEL-SCI scientists will present a paper regarding theirCEL-2000 (rheumatoid arthritis treatment based on L.E.A.P.S) inupcoming ACR/ARHP 2009.

Link to the presentation abstract… (10/18/2009)



Some information about the much talked about cold fill facility

Address:
6905 San Tomas Rd, Elkridge, Howard, Maryland 21075

HOWARD COUNTY  BUILDING MARKETING ANALYSIS/REPORT (PDF) (Howard County Website, Includes estimated building cost)

ANOTHER HOWARD COUNTY PDF REGARDING THE FACILITY

Hopefully this has helped you better understand the company and whatthey are trying to accomplish. Should you invest? The choice is yours.I know I am and so are the company insiders…

SEC website with the latest CEL-SCI Filings

Disclosure: Long on CVM